ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 48 filers reported holding ACORDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,000 | +36.4% | 21,148 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | -84.9% | 21,148 | -78.7% | 0.00% | -100.0% |
| Q2 2020 | $73,000 | -21.5% | 99,075 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $93,000 | -52.3% | 99,075 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $195,000 | -32.3% | 99,075 | -1.1% | 0.00% | -33.3% |
| Q3 2019 | $288,000 | -62.5% | 100,189 | 0.0% | 0.00% | -62.5% |
| Q2 2019 | $769,000 | -43.3% | 100,189 | -1.8% | 0.01% | -46.7% |
| Q1 2019 | $1,356,000 | -14.7% | 101,989 | 0.0% | 0.02% | -25.0% |
| Q4 2018 | $1,589,000 | -20.7% | 101,989 | 0.0% | 0.02% | +5.3% |
| Q3 2018 | $2,004,000 | -31.5% | 101,989 | 0.0% | 0.02% | -34.5% |
| Q2 2018 | $2,927,000 | +21.4% | 101,989 | 0.0% | 0.03% | +16.0% |
| Q1 2018 | $2,412,000 | +6.1% | 101,989 | -3.8% | 0.02% | +19.0% |
| Q4 2017 | $2,274,000 | -12.8% | 106,003 | -3.9% | 0.02% | 0.0% |
| Q3 2017 | $2,608,000 | +20.0% | 110,290 | 0.0% | 0.02% | +10.5% |
| Q2 2017 | $2,173,000 | -6.2% | 110,290 | 0.0% | 0.02% | -5.0% |
| Q1 2017 | $2,316,000 | +11.7% | 110,290 | 0.0% | 0.02% | +17.6% |
| Q4 2016 | $2,073,000 | -10.0% | 110,290 | 0.0% | 0.02% | -5.6% |
| Q3 2016 | $2,303,000 | -18.1% | 110,290 | 0.0% | 0.02% | -25.0% |
| Q2 2016 | $2,813,000 | -3.6% | 110,290 | 0.0% | 0.02% | -14.3% |
| Q1 2016 | $2,917,000 | -37.9% | 110,290 | +0.4% | 0.03% | -37.8% |
| Q4 2015 | $4,697,000 | +171.8% | 109,802 | +68.5% | 0.04% | +150.0% |
| Q3 2015 | $1,728,000 | -20.4% | 65,171 | 0.0% | 0.02% | -33.3% |
| Q2 2015 | $2,172,000 | +0.2% | 65,171 | 0.0% | 0.03% | +8.0% |
| Q1 2015 | $2,168,000 | – | 65,171 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|